A Double-Blind, Randomized, Placebo-Controlled, Phase 3 Study to Demonstrate Efficacy and Safety of A4250 in Children with Progressive Familial Intrahepatic Cholestasis Types 1 and 2 (PEDFIC 1)

drug protocol number
A4250-005
drug sponsor
Albireo
drug study
A4250-005
drug trial site
KFSH&RC-R
drug status
Completed
drug phase